baber/WOPTO huggingface dataset:
Patent IL-82459-A0 (IL)
Title: Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
IPC: A61K31/047
Filed: 1987-05-08
Abstract: These preparations are used for producing medicaments which are suitable for remedying prostaglandin deficiencies in humans and animals, for example curing or preventing diseases of the gastrointestinal tract.
Patent IL-99699-A0 (IL)
Title: Method of treating or preventing type 1 diabetes by oral administration of insulin
IPC: A61K38/39
Filed: 1991-10-09
Abstract: Disclosed herein are methods for treating or preventing a disease in mammals having the characteristics of Type 1 diabetes comprising administering insulin or disease suppressive fragments of insulin or analogs thereof in oral or aerosol dosage forms to said mammals. Also disclosed herein are pharmaceutical formulation or dosage forms for use in the methods.
Patent AU-PP395898-A0 (AU)
Title: Rubber compound
IPC: A63B43/00
Filed: 1998-06-05
Abstract: A golf ball is provided that includes a molded resilient inner core made of a rubber compound and a polymeric cover surrounding the inner core. The rubber compound is a halo-butyl rubber polymer and a carbon black filler in an amount of 80% to 100% by weight of the total rubber component.
Patent AU-PR093000-A0 (AU)
Title: Improved variable duration camshaft
IPC: F01L1/047
Filed: 2000-10-23
Abstract: A variable timing duration camshaft has an outer shaft (1) and coaxial inner shaft (2) adapted so that the shafts (1, 2) are relatively slidable but not rotatable about each other. The outer shaft (1) has valve control lobes located on its outer surface and a valve control lobe modifying segments (4) is located on the inner shaft (2) and is slidingly fitted into a mating slot (5) in the outer shaft and in the valve control lobe whereby longitudinal axial movement of the inner shaft (2) relative to the outershaft by a control means (13, 14) causes the modifying segment (4) to move longitudinally and circumferentially relative to the valve control lobes thereby varying the duration.
Patent FI-20075025-A0 (FI)
Inventor: POHJANEN PETRI
IPC: G16H30/20
Filed: 2007-01-17
Abstract: A system for data transfer comprises a server of a patient data system and an auxiliary server, which has installation data associated with at least one accepted device identifier available. The auxiliary server receives the identifier determining an examination device and transmits the installation data associated with the examination device identifier to the server of the patient data system. The server of the patient data system installs the identifier determining the examination device automatically on the basis of the installation data on the server of the patient data system for data transfer. Data is transferred between the examination device and the server of the patient data system after the identifier has been installed.
Patent IL-100264-A0 (IL)
Title: Heat exchanger
IPC: B23K26/00
Filed: 1991-12-06
Abstract: The heat exchanger consists of exchange tubes (2) which are narrow in the flow direction (SR) on the outer exchange medium. Two adjacent exchange tubes (2) are connected in each case by ribs (3a, 3b) either from U-shaped individual ribs or as a component of a meandering ribbed strip (14). The connection to the tube flanks (11) and the rib feet (9), and to the contact sections (16) is preferably performed by welding, in particular by fusion welding beams (20) from the insides (22) of the tube flanks (11). After two tube shells (7) have been connected via the ribs (3a, 3b), such a compound component is connected to a further such compound component by welding the longitudinal edges (6) of the tube shells (7). The tube ends are inserted in tube plates. Such a heat exchanger is completely galvanised and requires no supporting structures. <IMAGE>
Patent IL-100384-A0 (IL)
Title: Serotonin antagonists,their preparation and pharmaceutical compositions containing them
IPC: C07D453/02
Filed: 1991-12-16
Abstract: 3,7-disubstituted indole derivatives of formula I <CHEM> wherein R1, R2, n, X, Y and Z are as defined in the description, are useful for the treatment of psychiatric disorders.
Patent IL-108429-A0 (IL)
Title: Production of an anticoagulant composition
IPC: G01N33/49
Filed: 1994-01-25
Abstract: A process is disclosed for the production of an anticoagulant composition which allows for the accurate analysis of blood electrolyte concentrations. Also disclosed is the anticoagulant composition produced in accordance with the disclosed method and an apparatus containing said composition useful in the selection and sampling of blood.
Patent IL-111486-A0 (IL)
Title: Polymeric compositions for medical packaging and devices
IPC: C08L23/06
Filed: 1994-11-01
Abstract: A polymer based composition for fabricating into articles is described. The composition comprises:   a polypropylene in an amount by weight from 40-90% of the composition and having a melting temperature greater than 130 DEG C; a radio frequency susceptible polymer in an amount by weight from 5-50% of the composition and having a dielectric loss greater than 0.05 at 1-60 MHz and ambient temperature to 250 DEG C, the susceptible polymer being selected from (1) polymers containing at least one segment selected from the group consisting of urethanes, esters, ureas, imides, sulfones, and amides, and (2) ethylene copolymers having 50-85% ethylene content copolymerized with at least one monomer selected from the group consisting of acrylic acid, methacrylic acid, ester derivatives of acrylic acid with alcohols having 1-10 carbons, vinyl acetate, and vinyl alcohol; a compatibilizing polymer in an amount by weight from 5-30% of the composition, the compatibilizing polymer conferring compatibility between the radio frequency susceptible polymer, and the polypropylene, the compatibilizing polymer being a styrenic block copolymer with hydrocarbon soft segments, and wherein the composition has an optical haze value of less than 30% for the composition processed into a film of about 0.299 mm in thickness measured in accordance to ASTM D-1003, a mechanical modulus of less than 2758x10<5> Pa when measured according to ASTM D-882 and the composition exhibits no strain whitening after being strained at moderate speeds of about 50 cm per minute to about 100% elongation.
Patent IL-112955-A0 (IL)
Title: Imidazodiazepines, their preparation and pharmaceutical compositions containing them
IPC: A61K31/55
Filed: 1995-03-10
Abstract: Aminomethyl-substd. oxadiazolyl-imidazodiazepines of formula (I) and their addn salts are new: A and C atoms  alpha  and  beta form a gp of formula e.g. (A<1>):Q = a gp. of formula e.g. (Q<1>):R<1>, R<2> = H; lower alkyl,etc.;or NR<1>R<2> = 5-8 membered heterocycle opt. contg. a further hetero atom or carrying a fused benzene ring; R<3> = H and R<4> = lower alkyl; or R<3>+R<6> = H; halo;etc.; and C atom gamma  has the S configuration when R<3> is other than H.
Patent IL-117743-A0 (IL)
Title: Signal processing system
IPC: H04L27/22
Filed: 1996-03-31
Abstract: A circuit for processing modulated signals, comprising a semiconductor integrated carrier recovery circuit operative to control a demodulator, comprising :   an adaptive phase error estimation circuit executing a least-mean-square algorithm and comprising :   first and second slicers, accepting a derotated in-phase value and a derotated quadrature value respectively ; first and second subtracters, for respectively determining first and second differences between said derotated in phase value and said sliced in phase value, and between said derotated quadrature value and said sliced quadrature value ; and an angulator, accepting said first and second differences and outputting a phase error estimate ; and   a digital derotation circuit responsive to said phase error estimation circuit, and accepting an in phase component and a quadrature component of sampled signals.   <IMAGE>
Patent IL-136305-A0 (IL)
Title: Service control platform
IPC: H04M3/22
Filed: 2000-05-23
Abstract: The invention relates to a method of intercepting calls between two or more subscribers (A, B) of a communications networks (KOM) and to an interception manager and a service control platform for supporting the implementation of the method. For each of the calls, at least one of a plurality of service control points (SCP1 to SCP3) can be triggered by a service switching point (SSP1 to SSP3). The communications traffic between service switching points (SSP1 to SSP3) of the communications network and the service control points (SCP1 to SCP3) is routed through an interception manager (LIM) which is central to all service control points. The central interception manager (LIM) is triggered for a call when one (SCP1) of the service control points (SCP1 to SCP3) is triggered for this call by one (SSP1) of the service switching points (SSP1 to SSP3). When triggered for a call, the central interception manager (LIM) monitors the communications traffic between the respective service switching point (SSP1) and the respective service control point (SCP1) for the respective call and, based on information exchanged between the service switching point (SSP1) and the respective service control point (SCP1) and on predefined filter criteria, determines whether the call should be intercepted or not.
Patent IL-139133-A0 (IL)
Title: Method for treating waters, soils, sediments and/or sludges
Inventor: WILLUWEIT THOMAS
IPC: B09C1/08
Filed: 1999-05-12
Abstract: A method is providing for treating waters, such as standing and flowing waters and waste waters, soils, sediments and/or silts. At least one alkaline earth metal peroxide is brought into contact with such waters or the like, especially to effect immobilization of phosphates and heavy metals except manganese and iron therein.
Patent IL-143616-A0 (IL)
Title: A process for the preparation of antihistaminic piperidine derivatives
IPC: C07C49/798
Filed: 2001-06-06
Abstract: The present invention is related to novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of formula (I) wherein W represents -C(=O)- or -CH(OH)-; R 1  represents hydrogen or hydroxy; R 2  represents hydrogen; R 1  and R 2  taken together form a second bond between the carbon atoms bearing R 1  and R 2 ; n is an integer of from 1 to 5; m is an integer 0 or 1; R 3  is -COOH or -COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R 1  and R 2  are taken together to form a second bond between the carbon atoms bearing R 1  and R 2  or where R 1  represented hydroxy, m is an integer 0.
Patent IL-144684-A0 (IL)
Title: Pharmaceutical composition for oral administration
IPC: A61K9/14
Filed: 1996-07-12
Abstract: A pharmaceutical composition for oral administration in the form of a solid dispersion comprising an ascomycin or a derivative thereof and a carrier medium.
Patent IL-145777-A0 (IL)
Title: Macrolide antiinfective agents
IPC: C07H17/00
Filed: 2000-04-14
Abstract: Compounds of the formula wherein R<SUB>a </SUB>is H; substituted or unsubstituted alkyl (1-10C); substituted or unsubstituted alkenyl (2-10C); substituted or unsubstituted alkynyl (2-10C); substituted or unsubstituted aryl (4-14C); substituted or unsubstituted arylalkyl (5-20C); or OR<SUB>a </SUB>is replaced by H; R<SUB>b </SUB>is H or halogen; R<SUB>c </SUB>is H or a protecting group; R<SUB>d </SUB>is methyl, unsubstituted alkyl (3-10C); substituted alkyl (1-10C); substituted or unsubstituted alkynyl (2-10C); substituted or unsubstituted aryl (4-14C); substituted or unsubstituted arylalkyl (5-20C); substituted or unsubstituted arylalkenyl (5-20C); substituted or unsubstituted arylalkynyl (5-20C); substituted or unsubstituted amidoarylalkyl (5-20C); substituted or unsubstituted amidoarylalkenyl (5-20C); or substituted or unsubstituted amidoarylalkynyl (5-20C); R<SUB>e </SUB>is H or a protecting group; L is methylene or carbonyl; T is -O-, -N(R)-, -N(OR)-, -N(NHCOR)-, -N(N-CHR)-, or -N(NHR)- wherein R is H or R<SUB>a </SUB>as defined above, with the proviso that when L is methylene, T is -O-; one of Z and Y is H and the other is OH, protected OH, or amino, mono- or dialkylamino, protected amino, or an amino heterocycle or Z and Y together are -O, -NOH or a derivatized oxime; including any pharmaceutically acceptable salts thereof and any stereoisomeric forms and mixtures of stereoisomeric forms thereof, are antimicrobial agents.
Patent IL-151184-A0 (IL)
Title: Segment synthesis
IPC: G01N33/68
Filed: 2001-02-16
Abstract: The invention relates to the field of molecular recognition or detection of discontinuous or conformational binding sites or epitopes corresponding to a binding molecule, in particular in relation to protein-protein protein-nucleic acid, nucleic acid-nucleic acid or biomolecule-ligand interactions. The invention provides a synthetic molecular library allowing testing for, identification, characterisation or detection of a discontinuous binding site capable of interacting with a binding molecule, said library having been provided with a plurality of molecules, each molecule of said molecules comprising at least one first segment linked to a second segment, each segment having the capacity of being a potential single part of a discontinuous binding site.
Patent IL-151755-A0 (IL)
Title: Magnetic-based force/torque sensor
IPC: G01L3/10
Filed: 2001-03-28
Abstract: A force transducer element ( 20 ) comprises a body ( 22 ) of magnetisable material having at least one magnetised region ( 30 ) at an angle, say 45°, to the force-sensing direction (P-P). Preferably there are a plurality of parallel magnetised regions of alternating opposite polarity of magnetisation to form closed loops ( 43 p , 43 n). The element may be a block having opposite force receiving surfaces ( 24, 24 '). The body ( 122 ) may contain plural transducer elements ( 120 a, 120 b) angled to one another to resolve force directions. The principle is extended to a circular transducer element ( 243 ). The invention may be implemented in a flexible magnetic tape. Another embodiment ( 300 ) is realised in a planar structure in which a ferromagnetic core ( 310 ) is subject to a magnetic field ( 326 ) at an angle to the direction (F) of force application generated by laterally offset coils ( 312, 314 ). A sensor device ( 330 ) is fabricated in the structure.
Patent IL-155462-A0 (IL)
Title: Printhead for pen
IPC: B41J3/36
Filed: 2000-10-20
Abstract: The present invention provides an ink ejection type printhead having a plurality of ink ejection devices and a central axis, the ink ejection devices arranged in a series of groups, each of the groups generally extending along at least partially curved radial lines.
Patent IL-156331-A0 (IL)
Title: A process for the preparation of paclitaxel
IPC: C07D407/12
Filed: 2001-12-03
Abstract: A process for the preparation of paclitaxel starting from 10-deacetylbaccatine III.
Patent IL-166383-A0 (IL)
Title: Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release ofactive principle(s) with low solubility
IPC: A61K9/50
Filed: 2005-01-20
Abstract: The invention concerns microcapsules with prolonged release of active principles with low solubility, consisting of a core containing the active principle and coated with a polymer layer which controls the release of the active principle. The aim is that said oral microcapsules containing hardly soluble active principles, should have a coating film of sufficient thickness to ensure controlled permeability and should be adapted to industrial reproduction. This is achieved by the inventive microcapsules of mean diameter less than 1000 microns, and whereof the coating film contains a film-forming polymer (P1) insoluble in gastrointestinal tract fluids, a water-soluble polymer (P2), a plasticizer (PL), and optionally a lubricating surfactant (TA). Said microcapsules are characterized in that their coating films represents at least 3% p/p of dry matter, relative to their total weight and their core contains a hardly soluble active principle and a solubilizing agent (polyoxyethylene hydrogenated castor oil) which provides the core wherein it is contained with properties such that the behavior of the exposed core (non-coated) in a given dissolving test (TD), is as follows: release of 80% of active principle in less than two hours. The invention also concerns the use of such microcapsules in galenic formulation.
Patent IL-166559-A0 (IL)
Title: High performance continuous reaction/separation process using a liquid-solid contactor
IPC: C07C37/20
Filed: 2005-01-31
Abstract: A process for reaction and separation which comprises inputting a process material into at least one column of a plurality of columns wherein each column has at least one inlet for accepting flow from another column or group of columns, an external feed stream, an external eluent stream or a combination thereof, and each column has at least one outlet for connecting to another column, a group of columns, an external product stream or a combination thereof. Each column is independently operable in an up-flow or down-flow mode and connected independently to one of the group comprising another column, an external feed stream, an external eluent stream, an external product stream and combinations thereof.
Patent IL-166651-A0 (IL)
Title: Metalloprotease activation of myostatin and methods of modulating myostatin
IPC: C07K14/475
Filed: 2005-02-02
Abstract: The invention provides an  in vitro  method of decreasing myostatin activation. The method comprises contacting a sample comprising a latent myostatin complex comprising a myostatin pro peptide and a myostatin C-terminal fragment, and a metalloprotease that can cleave the myostatin pro peptide, with an agent that decreases proteolytic cleavage of the pro peptide by the metalloprotease, thereby decreasing myostatin activation. The metalloprotease is a bone morphogenic protein-1/tolloid (BMP-1/TLD) family member and the agent is a peptide selected from the group consisting of SEQ ID NOS: 9-23. Also provided is such an agent for use in decreasing myostatin activation in a subj ect.
Patent IL-169822-A0 (IL)
Title: System and method for treating fly ash
IPC: C04B18/08
Filed: 2005-07-21
Abstract: A method and system for treating fly ash with a treating fluid by evenly dispersing a treating fluid into a flowing stream of fly ash. By dispersing the treating fluid into the fly ash as the fly ash is flowing, the method takes advantage of natural mixing and particle motion that occurs during flow of the bulk solid. The application of treating fluid is advantageously controlled by an automated controller that has inputs and outputs that allow the controller to adjust flow rate of the treating fluid in correspondence with a measured flow rate of the fly ash.
Patent IL-178362-A0 (IL)
Title: Benzylidene-??-dicarbonyl compounds as novel uv-absorbers
IPC: A61K8/35
Filed: 2006-09-28
Abstract: Use of 1-phenyl-2-arylcarbonyl-ethylene derivatives (I) as UV filters in cosmetic formulations, especially in combination with UV filters of the methoxycinnamate and/or dibenzoylmethane types. Use of 1-phenyl-2-arylcarbonyl-ethylene derivatives of formula (I) as UV filters is cosmetic formulations, especially in combination with UV filters of the methoxycinnamate and/or dibenzoylmethane types. R 1>-R 3> each : hydrogen or 1-8C alkyl or alkoxy; R 4>COR, COOR or CON(R) 2; R : 1-8C alkyl or 3-8C cycloalkyl; R 5>hydrogen or 1-8C alkyl; and R 6>aryl, optionally substituted by 1-3 of 1-8C alkyl or alkoxy, or 3-8C cycloalkyl. With the proviso that R 5> = hydrogen when R 4> = COR. An independent claim is also included for (I) as new compounds when R 1> = para-1-8C alkoxy; R 2>, R 3> and R 5> = hydrogen; R 4> = 1-8C alkoxycarbonyl; R 6> = phenyl or cyclohexyl. [Image] ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.
Patent IL-180465-A0 (IL)
Title: Improved electric shaver
IPC: B26B19/00
Filed: 2006-12-31
Abstract: A hair cutting device (100) comprising: a housing (106); a detector adapted to detect motion of the device with respect to a skin surface (400) against which the device is juxtaposed; a hair cutting head (300) having a heated wire (260) suitable for heating hair growing from the skin, the hair cutting head being movable between a first, hair cutting position and a second retracted position at which the wire is removed from the vicinity of the skin; a controller (118) adapted to move the cutting head to the first position or to the second position when it does not responsive to said detected motion.
Patent IL-184264-A0 (IL)
Title: Method for the securing and monitoring of containers and container with securing and monitoring means
Filed: 2007-06-27
Abstract: A method of monitoring a container that holds goods, in which one or more surfaces of the container have an electrically conductive material that acts as a sensor to detect state changes in physical properties of the container, comprises obtaining state information from the electrically conductive material and determining a position of the container. The method further comprises associating the state information with the position of the container, detecting data about the goods from an RFID tag located on the goods via an antenna that is installed around the opening edge of the container when the goods are loaded into the container and passed by the antenna, and transmitting at least one of the state information, the position of the container or the data about the goods to a data processing unit.
Patent IL-228780-A0 (IL)
Title: Compositions for nhanced acaricidal activity
IPC: A01N53/00
Filed: 2013-10-08
Abstract: A composition for control of parasitic insects and acarids, comprising a combination of pyrethroids and chloronicotinyl compounds.
Patent IL-232210-A0 (IL)
Title: Novel anti-il 13 antibodies and uses thereof
IPC: C07K16/00
Filed: 2014-04-23
Abstract: The present invention relates to ant-IL-13 antibodies that bind specifically and with high affinity to both glycosylated and non-glycosylated human IL13, does not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MAb:IL13). The invention also relates to the use of these antibodies in the treatment of IL13-mediated diseases, such as allergic disease, including asthma, allergic asthma, non-allergic (intrinsic) asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, eczema, urticaria, food allergies, chronic obstructive pulmonary disease, ulcerative colitis, RSV infection, uveitis, scleroderma, and osteoporosis.